OSRH

Company Overview — What Does OSR Holdings, Inc. Do?

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea. OSR Holdings, Inc. (OSRH) is classified as a micro-cap stock in the Healthcare sector, specifically within the Medical Equipment industry. The company is led by CEO Harry Kim. With a market capitalization of $15M, OSRH is one of the notable companies in the Healthcare sector.

OSR Holdings, Inc. (OSRH) Stock Rating — Reduce (April 2026)

As of April 2026, OSR Holdings, Inc. receives a Reduce rating with a composite score of 28.8/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.OSRH ranks #2,849 out of 4,446 stocks in our coverage universe. Within the Healthcare sector, OSR Holdings, Inc. ranks #398 of 838 stocks, placing it in the upper half of its Healthcare peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

OSRH Stock Price and 52-Week Range

OSR Holdings, Inc. (OSRH) currently trades at $0.53. The stock gained $0.02 (3.4%) in the most recent trading session. The 52-week high for OSRH is $4.33, which means the stock is currently trading -87.8% from its annual peak. The 52-week low is $0.38, putting the stock 38.8% above its annual trough. Recent trading volume was 1.0M shares, reflecting moderate market activity.

Is OSRH Overvalued or Undervalued? — Valuation Analysis

OSR Holdings, Inc. (OSRH) carries a value factor score of 18/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 0.09x, versus the sector average of 2.75x. The price-to-sales ratio is 5.00x, compared to 1.66x for the average Healthcare stock.

At current multiples, OSR Holdings, Inc. trades at a premium to most Healthcare peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

OSR Holdings, Inc. Profitability — ROE, Margins, and Quality Score

OSR Holdings, Inc. (OSRH) earns a quality factor score of 30/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -14.9%, compared to the Healthcare sector average of -43.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -11.3% versus the sector average of -33.1%.

On a margin basis, OSR Holdings, Inc. reports gross margins of 22.1%, compared to 71.5% for the sector. The operating margin is -470.8% (sector: -66.1%). Net profit margin stands at -718.4%, versus -58.7% for the average Healthcare stock. Revenue growth is running at -23.7% on a trailing basis, compared to 10.6% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

OSRH Debt, Balance Sheet, and Financial Health

OSR Holdings, Inc. has a debt-to-equity ratio of 32.0%, compared to the Healthcare sector average of 32.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 0.21x, which may signal near-term liquidity tightness. Total debt on the balance sheet is $2M. Cash and equivalents stand at $2M.

OSRH has a beta of -0.30, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for OSR Holdings, Inc. is 32/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

OSR Holdings, Inc. Revenue and Earnings History — Quarterly Trend

In TTM 2026, OSR Holdings, Inc. reported revenue of $3M and earnings per share (EPS) of $-0.10. Net income for the quarter was $-20M. Gross margin was 22.1%. Operating income came in at $-12M.

In Q3 2025, OSR Holdings, Inc. reported revenue of $627,747 and earnings per share (EPS) of $-0.10. Net income for the quarter was $-3M. Gross margin was 41.7%. Operating income came in at $-4M.

In Q2 2025, OSR Holdings, Inc. reported revenue of $1M and earnings per share (EPS) of $0.02. Net income for the quarter was $-5M. Gross margin was 2.9%. Operating income came in at $-5M.

In Q1 2025, OSR Holdings, Inc. reported revenue of $761,272 and earnings per share (EPS) of $-1.04. Net income for the quarter was $-11M. Gross margin was 22.2%. Revenue grew -16.4% year-over-year compared to Q1 2024. Operating income came in at $-3M.

Over the past 8 quarters, OSR Holdings, Inc. has demonstrated a growth trajectory, with revenue expanding from $910,225 to $3M. Investors analyzing OSRH stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

OSRH Dividend Yield and Income Analysis

OSR Holdings, Inc. (OSRH) does not currently pay a dividend. This is common among smaller companies in the Medical Equipment industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Healthcare dividend stocks may want to explore other Healthcare stocks or use the stock screener to filter by dividend yield.

OSRH Momentum and Technical Analysis Profile

OSR Holdings, Inc. (OSRH) has a momentum factor score of 18/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 25/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 69/100 reflects moderate short selling activity.

OSRH vs Competitors — Healthcare Sector Ranking and Peer Comparison

Within the Healthcare sector, OSR Holdings, Inc. (OSRH) ranks #398 out of 838 stocks based on the Blank Capital composite score. This places OSRH in the upper half of all Healthcare stocks in our coverage universe. Key competitors and sector peers include ASTRAZENECA PLC (AZN) with a score of 61.4/100, Sol-Gel Technologies Ltd. (SLGL) with a score of 56.6/100, VIEMED HEALTHCARE, INC. (VMD) with a score of 53.4/100, Innoviva, Inc. (INVA) with a score of 52.7/100, and JOHNSON & JOHNSON (JNJ) with a score of 51.7/100.

Comparing OSRH against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full OSRH vs S&P 500 (SPY) comparison to assess how OSR Holdings, Inc. stacks up against the broader market across all factor dimensions.

OSRH Next Earnings Date

No upcoming earnings date has been announced for OSR Holdings, Inc. (OSRH) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy OSRH? — Investment Thesis Summary

The quantitative profile for OSR Holdings, Inc. suggests caution. The quality score of 30/100 flags below-average profitability. The value score of 18/100 indicates premium valuation. Momentum is weak at 18/100, a headwind for near-term performance. High volatility (stability score 32/100) increases portfolio risk.

In summary, OSR Holdings, Inc. (OSRH) earns a Reduce rating with a composite score of 28.8/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on OSRH stock.

Related Resources for OSRH Investors

Explore more research and tools: OSRH vs S&P 500 comparison, top Healthcare stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare OSRH head-to-head with peers: OSRH vs AZN, OSRH vs SLGL, OSRH vs VMD.